John V. Balen, Director at Cardlytics, Inc. (CDLX), bought 2,000 shares at $78.61 ($160K) on 2021-08-19, disclosed to the SEC on 2021-08-23.
Open-market purchase of $160k CDLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.61 | 1,000 | $79K | 49.1% |
| 2 | $81.41 | 1,000 | $81K | 50.9% |
| Total | $80.01 avg | 2,000 | $160K | 100% |
| Filing → |
| CDLX | BUY | 2022-05-31 | $137K | — | Filing → |
| CDLX | BUY | 2022-05-10 | $88K | — | Filing → |
| CDLX | BUY | 2021-08-31 | $90K | — | Filing → |